Zeyad Sahli1, Alireza Najafian1, Stacie Kahan1, Eric B Schneider1, Martha A Zeiger1, Aarti Mathur2. 1. Department of Surgery, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 606, Baltimore, MD, 21287, USA. 2. Department of Surgery, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 606, Baltimore, MD, 21287, USA. amathu10@jhmi.edu.
Abstract
INTRODUCTION: Hypocalcemia is a well-known complication after total thyroidectomy. Studies have indicated that the presence of low postoperative parathyroid hormone (PTH) levels can predict hypocalcemia. However, definitive study designs are lacking. The aim of this study was to determine whether postoperative PTH alone can accurately predict postoperative biochemical hypocalcemia. METHODS: Under IRB approval, a prospective study of 218 consecutive patients who underwent total or completion thyroidectomy by two surgeons between June 2014 and June 2016 was performed. Biochemical hypocalcemia was defined as ionized calcium <1.13 mmol/L or serum calcium <8.4 mg/dL at any time postoperatively. Three PTH thresholds, <10, <20 pg/mL, and >50% drop in PTH 1 h postoperatively from baseline were examined. RESULTS: Postoperative PTH < 10 pg/mL had a sensitivity of 36.5% (95% CI 27.4-46.3%) and a specificity of 89.2% (95% CI 81.9-94.3%). Postoperative PTH < 20 pg/mL had a sensitivity of 66.4% (95% CI 56.6-75.2%) and a specificity of 67.6% (95% CI 58.0-76.2%). Postoperative PTH decrease >50% had a sensitivity of 63.4% (95% CI 53.2-72.7%) and a specificity of 72.5% (95% CI 62.5-81.0%). Across all PTH thresholds, the false-negative rate was 33.6-63.5% indicating that up to 64% of patients with a normal PTH level could have been discharged without appropriate calcium supplementation. The false-positive rate was 10.8-32.4% indicating that up to 32.4% of patients with low PTH could have been treated with calcium supplementation unnecessarily. CONCLUSION: Following total thyroidectomy, PTH levels are unreliable in predicting hypocalcemia. Additional prospective studies are needed to understand the true utility of PTH levels post-thyroidectomy.
INTRODUCTION:Hypocalcemia is a well-known complication after total thyroidectomy. Studies have indicated that the presence of low postoperative parathyroid hormone (PTH) levels can predict hypocalcemia. However, definitive study designs are lacking. The aim of this study was to determine whether postoperative PTH alone can accurately predict postoperative biochemical hypocalcemia. METHODS: Under IRB approval, a prospective study of 218 consecutive patients who underwent total or completion thyroidectomy by two surgeons between June 2014 and June 2016 was performed. Biochemical hypocalcemia was defined as ionizedcalcium <1.13 mmol/L or serum calcium <8.4 mg/dL at any time postoperatively. Three PTH thresholds, <10, <20 pg/mL, and >50% drop in PTH 1 h postoperatively from baseline were examined. RESULTS: Postoperative PTH < 10 pg/mL had a sensitivity of 36.5% (95% CI 27.4-46.3%) and a specificity of 89.2% (95% CI 81.9-94.3%). Postoperative PTH < 20 pg/mL had a sensitivity of 66.4% (95% CI 56.6-75.2%) and a specificity of 67.6% (95% CI 58.0-76.2%). Postoperative PTH decrease >50% had a sensitivity of 63.4% (95% CI 53.2-72.7%) and a specificity of 72.5% (95% CI 62.5-81.0%). Across all PTH thresholds, the false-negative rate was 33.6-63.5% indicating that up to 64% of patients with a normal PTH level could have been discharged without appropriate calcium supplementation. The false-positive rate was 10.8-32.4% indicating that up to 32.4% of patients with low PTH could have been treated with calcium supplementation unnecessarily. CONCLUSION: Following total thyroidectomy, PTH levels are unreliable in predicting hypocalcemia. Additional prospective studies are needed to understand the true utility of PTH levels post-thyroidectomy.
Authors: A Bergenfelz; S Jansson; A Kristoffersson; H Mårtensson; E Reihnér; G Wallin; I Lausen Journal: Langenbecks Arch Surg Date: 2008-07-17 Impact factor: 3.445
Authors: Noah Sands; Jonathan Young; Elizabeth MacNamara; Martin J Black; Michael Tamilia; Michael P Hier; Richard J Payne Journal: Otolaryngol Head Neck Surg Date: 2011-02-18 Impact factor: 3.497
Authors: Avi Khafif; Arie Pivoarov; Jesus E Medina; Avraham Avergel; Ziv Gil; Dan M Fliss Journal: Otolaryngol Head Neck Surg Date: 2006-06 Impact factor: 3.497
Authors: Richard J Payne; Marc A Tewfik; Michael P Hier; Michael Tamilia; Elizabeth Mac Namara; Jonathan Young; Martin J Black Journal: Otolaryngol Head Neck Surg Date: 2005-09 Impact factor: 3.497
Authors: David J Terris; Samuel Snyder; Denise Carneiro-Pla; William B Inabnet; Emad Kandil; Lisa Orloff; Maisie Shindo; Ralph P Tufano; R Michael Tuttle; Mark Urken; Michael W Yeh Journal: Thyroid Date: 2013-09-14 Impact factor: 6.568
Authors: J Pieter Noordzij; Stephanie L Lee; Victor J Bernet; Richard J Payne; Seth M Cohen; Ian K McLeod; Michael P Hier; Martin J Black; Paul D Kerr; Melanie L Richards; Chung Yau Lo; Marco Raffaelli; Rocco Bellantone; Celestino P Lombardi; James I Cohen; Mary S Dietrich Journal: J Am Coll Surg Date: 2007-09-18 Impact factor: 6.113
Authors: S Mattoo; A Agarwal; S Mayilvaganan; P Mishra; G Agarwal; A Mishra; G Chand; S K Gupta; S K Mishra Journal: J Endocrinol Invest Date: 2021-01-27 Impact factor: 4.256
Authors: Kathrin Nagel; Anne Hendricks; Christina Lenschow; Michael Meir; Stefanie Hahner; Martin Fassnacht; Armin Wiegering; Christoph-Thomas Germer; Nicolas Schlegel Journal: BJS Open Date: 2022-09-02